Russell Investments Group, Ltd.
Position in RGC — Regencell Bioscience Holdings Ltd
CIK 1692234
Seattle, WA
Position in RGC
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,628
-$14,698 QoQ
Shares Held
760
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 35 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. RGC ranks #44 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
893,500 | $64,206,902 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
329,065 | $55,460,607 | |
| 3 | VTRS |
Viatris Inc
|
3,423,675 | $54,367,956 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
61,355 | $33,243,974 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,112,894 | $27,388,318 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
147,146 | $16,324,370 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
427,444 | $14,481,798 | |
| 8 | ALKS |
Alkermes plc.
|
222,624 | $11,665,496 |
All Filings in RGC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,628 | 760 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $19,326 | 760 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||